Brief: Aravive To Present New Data From Phase 1B Trial On AVB-500 In Clear Cell Renal Cell Carcinoma At Society For Immunotherapy Of Cancer

Aravive

01/10/2021 13:23

Oct 1 (Reuters) - Aravive Inc  ARAV.O :
    * ARAVIVE TO PRESENT NEW PRELIMINARY DATA FROM PHASE 1B
TRIAL ON
AVB-500 IN CLEAR CELL RENAL CELL CARCINOMA AT SOCIETY FOR
IMMUNOTHERAPY OF CANCER

Further company coverage:  ARAV.O 

 ((Reuters.Briefs@thomsonreuters.com;))